Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation

Transplantation

Volumn 67, Issue 1, 1999, Pages 78-84

  Gane, Edward J ^a   Maertens, Geert ^b   Ducatteeuw, Annemie ^b   Qian, Ke Ping ^c   Lau, Johnson Y N ^c   Jones, Huw ^a   Davies, Edward ^a   Naoumov, Nikolai V ^a,d   Williams, Roger ^a,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INNOGENETICS   (Belgium)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; HEPATITIS C ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; HEPATITIS C; HUMAN; IMMUNOASSAY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; VIREMIA;

CRYOGLOBULINS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; POSTOPERATIVE COMPLICATIONS; RECURRENCE; VIRAL ENVELOPE PROTEINS; VIREMIA;

EID: 0033556649     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00013     Document Type: Article

References (45)

1. Shah G, Demetris J, Gavaler J, et al. Incidence, prevalence and clinical course of hepatitis C following liver transplantation. Gastroenterology 1992; 103: 323.
2. Chazouilleres O, Kim M, Coombes C, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994.
3. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317.
4. Zaaijer H, Vrielink H, van Exel-Oehlers P, Cuypers H, Lelie P. Confirmation of hepatitis C infection: a comparison of five immunoblot assays. Transfusion 1994; 34: 603.
5. Lok A, Chien D, Choo Q, et al. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppresssed patients. Hepatology 1993; 18: 497.
6. Chien D, Choo Q, Ralston R, et al. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 1993; 342: 933.
7. Cerino A, Nicosia A, Esumi M, et al. Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA+ patients. J Hepatol 1995; 23: 92.
8. Yoshioka K, Aiyama T, Takayanagi M, Okumura A, Iwata K. Detection of serum antibodies to E2 HVR I hypervariable region of hepatitis C virus. Hepatology 1994; 20: 232A.
9. Agnello V, Chung R, Kaplan L. A role of hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490.
10. Farahvash M, Ghosh S, Osborn T, Bacon B. Cryoglobulinemia is common in patients with chronic HCV. Hepatology 1993; 18: 231A.
11. Hijikata M, Shimizu YK, Kato H, et al. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 1993; 67: 1953.
12. Choo S, So H, Cho JM, Ryu W. Association of hepatitis C virus particles with immunoglobulins: a mechanism for persistent infection. J Gen Virol 1995; 76: 2337.
13. Adinophi L, Utili R, Attanasio V, et al. Mixed cryoglobulinaemia in chronic hepatitis C: clinical features and α interferon treatment. J Hepatol 1994; 21: S39.
14. Bichard P, Ounanian A, Girard M, et al. High prevalence of HCV RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinaemia. J Hepatol 1994; 21: 58.
15. Lunel F, Musset L, Cacoub P, et al. Cryoglobulinaemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291.
16. Van Thiel D, Fagiuolo P, Wright H, Nadir A, Gavaler J, Zuhdi N. Cryoglobulinaemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive liver disease. J Hepatol 1995; 22: 464.
17. van Doorn L, Kleter B, Stuyver L, et al. Analysis of HCV genotypes by a line probe assay and correlation with antibody profiles. J Hepatol 1994; 21: 122.
18. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513.
19. Tilston P, Morris D, Klapper P, Corbitt G. Commercial assay for hepatitis C RNA. Lancet 1994; 344: 201.
20. Gerken G, Pontisso P, Roggendorf M, et al. Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA. J Hepatol 1996; 24: 33.
21. Davis GL, Lau JYN, Urdea MS, et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994; 19: 1337.
22. Urdea MS, Horn T, Fultz TJ, et al. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Res Symp Ser 1991; 24: 197.
23. Maertens G, Ducatteeuw A, Stuyver L, et al. Low prevalence of anti-E1antibodies reactive to recombinant type 1b E1 envelope protein in type 2, 3 and 4 HCV sera, but high prevalence in subtypes 1a and 1b. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis and liver disease. Tokyo: Springer Verlag, 1993; 314.
24. Brouet J, Clauvel J, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775.
25. Yuki N, Hayashi N, Kasahara A, et al. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection. Hepatology 1996; 23: 947.
26. Hsu H, Donets M, Greenberg HB, Feinstone SM. Characterisation of hepatitis C virus structural proteins with a recombinanat baculovirus expression system. Hepatology 1993; 117: 763.
27. Maertens G, Ducatteeuw A, Barlet V, et al. E1 antibody level monitoring predicts long-term resolution of hepatitis C virus infection. J Hepatol 1995; 23 (Suppl 1): 88.
28. Jeffers L, Banks A, Jonalagadda S, et al. E1 antibody level monitoring predicts long-term response of hepatitis C infection in patients treated with interferon. Hepatology 1995; 22: 291A.
29. Lau JYN, Davis GL, Brunson ME, et al. Hepatitis C virus infection in kidney transplant recipients. Hepatology 1993; 18: 1027.
30. Oliva JA, Maymo RM, Carrio J, Delgado O, Mallafre JM. Late seroconversion of C virus markers in haemodialysis patients. Kidney Int 1993; 43: S153.
31. Bukh J, Wantzin P, Krogsgaard K, Knudsen F, Purcell R, Miller RH. High prevalence of HCV RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 1993; 168: 1343.
32. Bjoro K, Froland S, Yun Z, Samdal H, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinaemia after treatment with contaminated immune globulin. N Engl J Med 1994; 331: 1607.
33. Gane E, Naoumov NV, Qian K, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 108: 167.
34. DiMartino V, Saurini F, Samuel D, et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology 1997; 26: 1343.
35. Martinot-Peignoux M, Boyer N, Pouteau M, et al. Predictors of sustained response to α-interferon therapy in chronic hepatitis C. J Hepatol 1998; 29: 214.
36. Farci P, Alter H, Wong D, et al. Prevention of hepatitis C infection in chimpanzees after antibody-mediated in vitro neutralisation. Proc Natl Acad Sci USA 1994; 91: 7792.
37. Agnello V, Chung R, Kaplan L. A role of hepatitis C virus infection in type II cryoglobulinaemia. N Engl J Med 1992; 327: 1490.
38. Farahvash M, Ghosh S, Osborn T, Bacon B. Cryoglobulinaemia is common in patients with chronic HCV. Hepatology 1993; 18: 231A.
39. Ferri C, La Civita L, Longombardo G, Greco F, Bombardieri S. Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest 1993; 23: 399.
40. Van Thiel D, Fagiuolo P, Wright H, Nadir A, Gavaler J, Zuhdi N. Cryoglobulinaemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive liver disease. J Hepatol 1995; 22: 464.
41. Gournay J, Ferrell LD, Roberts JP, Ascher NL, Wright TL, Lake JR. Cryoglobulinaemia presenting after liver transplantation. Gastroenterology 1996; 110: 265.
42. Selby MJ, Choo QL, Berger K, et al. Expression, identification and subcellular localisation of the proteins encoded by the hepatitis C genome. J Gen Virol 1993; 74: 1103.
43. Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinaemia. Ann Intern Med 1992; 117: 573.
44. Rahamimov R, Ilan Y, Eid A, Shouval D, Tur-Kaspa R. Hepatitis C-associated cryoglobulinaemia after liver transplantation. Transplantation 1995; 60: 1050.
45. Ishitani M, McGory R, Dickson R, et al. Late hepatic artery thrombosis: a potential complication of viral hepatitis. Hepatology 1996; 24: 293A.